強気
$0.63
シナリオ価格
$0.610
+0.006 (+1.04%)終値時点
DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.
DSS Inc is not a good buy right now due to significant financial losses and negative trends. The current price is $0.61, and the company has a forward P/E ratio of 0, indicating a lack of earnings potential. Additionally, the gross margin is negative at -25.39%, which reflects ongoing profitability issues. The main risk is the high debt-to-equity ratio of 439.61%, indicating potential solvency concerns.
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

DSS Inc. Cancels Proposed Public Offering

DSS, Inc. Launches Public Offering of Common Stock

DSS Withdraws S-1 Registration Statement Amid Market Conditions

DSS Announces 2025 Fiscal Year Audit Report with Going Concern Qualification

Insider at DSS Inc (DSS.US) Plans to Sell $23.06 Million in Common Stock via Form 144
DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing. It operates in the Basic Materials sector (PAPERBOARD CONTAINERS & BOXES industry).
DSS Inc is not a good buy right now due to significant financial losses and negative trends. The current price is $0.61, and the company has a forward P/E ratio of 0, indicating a lack of earnings potential. Additionally, the gross margin is negative at -25.39%, which reflects ongoing profitability issues. The main risk is the high debt-to-equity ratio of 439.61%, indicating potential solvency concerns.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。